Audrey’s Updated Selected Meeting Picks for June 2009
(June 20th Edition)
******************************************************************************************
Palo Alto AWIS, Monday Evening, June 22, 2009
Topic: “Interviewing for Industry: How We Do It at Genencor”
Speaker: Lisa Zanetto and Emma Cuttler, HR leaders at Genencor
Date and Time: Monday, June 22, 2009
Schedule
7:00-7:30 pm Networking and light supper
7:30-7:45 pm Announcements
7:45-8:45 pm Program
8:45-9:00 pm Discussion
Location: PARC Auditorium, 3333 Coyote Hill Road, Palo Alto
RSVP: online http://www.acteva.com/go/pa-awis
Welcome!! You donʼt need to be a member to attend.
All scientists, students, and their friends are welcome. Men too!
Members pay $4 and non-members pay $7 to offset the cost of food.
Topic Description
So you want to find a job in industry! How can you find the right job? Where should you
How should you prepare for the actual interview? What questions should you expect from
the interviewers? Lisa Zanetto and Emma Cuttler, HR leaders at Genencor, will share with
you their tips and tricks from all of their experience in recruiting for different capacities.
Speaker Bios
Lisa look for open positions especially in a down economy? What should be on your resume?
Zanetto is HR Director for the Research & Development and Legal & Regulatory teams at
Genencor. Before Genencor, Lisa was director of HR at Galileo Pharmaceuticals. Before Galileo,
Lisa worked for Evant Solutions, a worldwide management consulting and systems integration firm.
Lisa received her Bachelor’s of Science in Applied Behavioral Science from UC Davis.
Emma Cuttler has international experience with recruitment. - After working in a recruiting capacity
in Australia, and at Danisco Head Quarters in Denmark, Emma moved to Genencor division in Palo
Alto. Currently at Genencor, she supports the R&D group as an HR Generalist. Emma received
her Bachelor’s in Human Resource Mgt from Queensland University of Technology, Australia.
Meet fellow AWIS members who share similar professional interests.
Directions from 280:
Take Hwy 280 and exit at Page Mill Rd and go East towards Palo Alto (if coming from the South, turn right, if coming from
the north, turn left onto Page Mill. Turn RIGHT onto Coyote Hill Rd. Turn LEFT into PARC (formerly Xerox PARC). Follow
signs to the Auditorium on your left at end of parking area, down flight of outdoor stairs.
Directions from Stanford: Take Foothill SOUTH towards Los Altos. Turn RIGHT on Hill view and PARC is 2nd driveway
on the right. Park and follow signs to the Auditorium (walk uphill through parking lot then down a flight of outdoor stairs).
**************************************************************************
Bio2Device Group, Tuesday Morning, June 23, 2009
Topic: “Frontiers of the Medical Device Industry: India as a Market and Source of Innovation”
Speaker: Anurag Mairal, Ph.D. MBA, Associate Director, Program Development, Stanford India Biodesign Group
Date and Time: Tuesday, June 23, 2009, 8:30 – 10:30 am
Location: Sunnyvale City Council Chambers, 456 W. Olive, Sunnyvale, CA (across the street from Sunnyvale Public Library)
Cost: Free
Parking on street and in NOVA and library parking lots across the street
See details at www.Bio2DeviceGroup.org
Topic Description
This presentation focuses on the healthcare market, and in particular the fast-growing medtech segment, in India. Healthcare in the developed world, especially in the U.S. is undergoing a paradigm shift. As the cost of healthcare soars, policy makers and industry alike are scrambling to address the issue before it reaches untenable proportions. Across the continents, the emerging markets of Brazil, Russia, India, and China are going through a parallel transformation. These markets are experiencing a double digit growth, fuelled by the growth in their economies, the investments in healthcare infrastructure, regulatory and policy changes, and most importantly, a vibrant but nascent healthcare industry with country-specific innovation. In this presentation, the speaker will discuss the drivers of growth in the medtech industry in India and the barriers facing it. The talk will also discuss the opportunities for the industry and academia in the U.S. in enabling the medtech industry in India. As a case study, the speaker will discuss a new partnership between Stanford and two of the leading academic institutions in India – All India Institute of Medical Sciences and Indian Institute of Technology Delhi – that aims to address some of the challenges in India. The partnership, called Stanford India Biodesign, is focused on developing a strong ecosystem, training the next generation of medtech innovation leaders, and creating new medtech products to serve the clinical needs of the India. Speaker will end with examples that hint at the possibility that the innovation emerging out of India may diffuse westward and provide the U.S. with cost-effective solutions sorely needed.
Speaker Bio
Dr. Anurag Mairal is the Associate Director, Program Development with the Stanford India Biodesign program at the Stanford University. In this role, Dr. Mairal is responsible for developing an extensive network of partners from the industry, academia, regulatory bodies, and investors in India and the U.S. to foster the India-focused program. In his spare time, Dr. Mairal is working on a new venture that provides services to the medical device industry using global resources; the venture relies heavily on highly trained clinicians and qualified vendors in India, Singapore, and China. Prior to this, Dr. Mairal was a Product Director at Cordis and a Development Director, Business Development at Nitinol Devices and Components, both Johnson and Johnson companies. Before joining J&J, Dr. Mairal was the Lead Partner for the life sciences practice of Market Potential, a consulting firm focused on early stage companies. Earlier, he was a Group Leader and a Process Development Manager at Membrane Technology and Research (MTR). At MTR, Dr. Mairal was responsible for fundraising, business development, strategic alliances, and product development in the Bioseparations area. Dr. Mairal has received a Bachelor of Engineering degree from Ravishankar University, Raipur; a Master of Technology degree from the Indian Institute of Technology, Bombay; and a Ph.D. from the University of Colorado at Boulder, where he pursued graduate research in membrane separations. Dr. Mairal was also a post-doctoral fellow at the University of Twente, Netherlands and at University of Michigan, Ann Arbor. Dr. Mairal has an MBA from the Haas School of Business at University of California, Berkeley. At Haas, he was a founding co-Chairman of the South Asia Business Conference and Chair of the Biotech Panel for the Asia Business Conference. Dr. Mairal is also a Co-founder and President Elect of South Asian MBA Association (SAMBAA), a global network of MBAs with interest in South Asia. Dr. Mairal has over 20 publications and 7 issued patents
************************************************************************
Free Webcast Hosted by MX and Sponsored by SAP, Tuesday Noon, June 23, 2009
Topic: “Making Manufacturing Work More Efficiently”
Panelists for the Webcast include::
“State of the Union: Life Science Manufacturing Compliance”
Christopher McNally
Executive Vice President
Arbour Group
“Automating Compliance in Manufacturing”
Bradley Ison
Principal, Manufacturing Solutions: Consumer Products and Life Sciences Sector
SAP America Inc.
IDEXX Laboratories Electronic Batch Record Initiative
Suzanne M. Rochon
IT Manager II
IDEXX Laboratories Inc.
The Webcast will conclude with a
live Q&A session moderated by
Sherrie Conroy
Editor-in-Chief of MX.
Date and Time: Tuesday, June 23, 2009; 12:00 am PDT
Who Should Attend: Executive and senior management involved in IT, product design, regulatory compliance, manufacturing, and quality systems initiative
Cost: Free
TO REGISTER
CLICK HERE
Topic Description
Rapidly changing costs, inconsistent quality, increased global competition, new business risks, and regulations are putting a variety of pressures on manufacturers and challenging their profitability. Forced to do more with less, both people and processes are running under unprecedented strain in an effort to meet customer and regulatory requirements. What’s needed are ways to make manufacturing operations work more efficiently to improve the future of the business. One way to build that future is through what SAP calls “Compliant Manufacturing Operations.” It’s a completely integrated—enterprise to plant—manufacturing solution that can be implemented in steps that will quickly drive customer ROI. In this FREE Webcast, "Making Manufacturing Work More Efficiently," hosted by MX and sponsored by SAP, industry experts discuss how the “Compliant Manufacturing Operations” solution provides a continuous improvement framework to improve quality, ensure compliance and lower manufacturing costs.
********************************************************************************
Biotech Beach Career Fair, Wednesday, June 24, 2009, 1pm - 6pm
Date and Time: Wednesday, June 24, 2009, 1pm - 6pm
Location:Manchester Grand Hyatt, San Diego, California
Cost: Free
Event Description
BioSpace is proud to present the Biotech Beach Career Fair, an opportunity for leading pharmaceutical and biotech companies to meet face-to-face with job seekers.
Do not miss the chance to interview with the biopharmaceutical industry's most prestigious companies!
All candidates must have at least a four-year college degree and two years of industry related work experience to attend. (Equivalent work experience may be considered in lieu of a four-year college degree.)
Qualified candidates will receive their invitations and confirmation numbers via email no later than 72 hours prior to the career fair. Pre-screened and accepted candidates must bring a copy of their invitation with confirmation number to the event.
Click here to pre-register now or http://www.biospace.com/jobs/career-fair-detail/?CareerFairId=175&type=email&source=cf-BiotechBeach-js-06-10-09
We look forward to seeing you at the BioSpace Career Fair!
BioSpace Career Fair Team
9100 E. Panorama Dr.
Englewood, CO 80112
***********************************************************************
LES Silicon Valley, Wednesday Lunchtime, June 24, 2009
Topic: “Settlement Agreements – A Boon or Burden: How to Protect Your Company From Making Mistakes That Will Cost in the Long Run”
Speakers:
Paul J. Meyer, Jr. is a counsel in O'Melveny & Myers LLP's Silicon Valley office and a member of the firm's Intellectual Property and Technology practice. His practice focuses on intellectual property counseling, and structuring and negotiating technology transactions, including licensing, joint ventures, complex strategic alliances and mergers and acquisitions.
George Yu is a counsel in O'Melveny's San Francisco office and a member of the Intellectual Property and Technology Practice Group within the Litigation Department. George focuses his practice on intellectual property litigation and counseling with an emphasis on patent infringement and technology-related trade secret misappropriation actions. With a strong background in biochemistry and biology, George has particular experience handling matters involving complex biotechnology and medical technology products. George also has experience handling matters involving high tech and software products.
Date and Time: Wednesday, June 24, 11:30 AM – 2:00 PM
Location: Hosted by TIPS Group , 1000 Elwell Court, Suite 150, Palo Alto, CA 94303, (650) 293-3350
Click here for detailed information and online registration
LES Members
Early, by June 19: $45
After June 19: $50
Non-Members
Early, by June 19: $50
After June 19: $55
Members of the following organizations will receive the LES Member rate:
ALM, Bay Bio, The Churchill Club, International Business Forum, LARTA, Ocean Tomo, Patent Café, Practicing Law Institute, San Jose Bio, Tech Connect
For Questions about the Meeting:
Franca Gargiulo
LES –SVC Coordinator
(415) 564-2600
Topic Description:
In an effort to conclude expensive and disruptive intellectual property litigation, a party may enter into a settlement agreement that resolves the current dispute, but does not satisfactorily address the party’s long-term strategic goals. For example, settlement agreements may include terms that cause a company to become an unattractive merger candidate. This presentation will offer advice on best practices for negotiating and drafting settlement agreements in the context of on-going litigation, and provide examples of “pitfalls” for settlement agreements and suggestions on how to avoid them. The presentation will also address issues related to licensing schemes that are often part of settlement agreements.
Topics will include:
· Deciding if a settlement agreement will cover improvements, enhancements, updates, or modifications of the intellectual property in dispute.
· Identifying proper entities (e.g., members of a party’s supply chain) in waivers and releases.
· Differentiating between covenants not-to-sue and licenses as they relate to settlement of litigation, and lessons learned from the recent Federal Circuit opinion in Transcore, LP et al. v. Electronic Transaction Consultants Corp.
· Structuring payment schemes (e.g., royalty payments) in licenses so that the underlying business is not overly burdened.
· Ensuring that necessary on-going rights are transferrable or available to potential acquirers or partners.
· Avoiding antitrust pitfalls that arise out of settlement agreements.
· Identifying other strategic issues relating to the settlement process.
************************************************************************************
Intensive Bioscience Business Development Course, All Day, June 25-26, 2009
Event: Intensive 2-day course in Business Development and Licensing-“Bioscience Business Development: Building Value”
Instructors and Topics:
· Audrey Erbes, Ph.D., Principal, Erbes & Associates, “Business Development in the Bioscience Industry”
· Gil Mintz, Ph.D., President, GRM Associates, “Working Your Way Through the Bioscience Licensing Process: Licensing - The Process”
Expert Guest Lecturers and Topics:
· Harold (Hal) Etterman, MBA, CEO, Knight Financial Plans & Services, LLC, “Financing a Bioscience Company: Financial Matters for New, Emerging and Established Entities”
· Carolyn Feamster, MBA, Consultant, Business Strategy & Analysis, "Preparing for and Planning Deals for Maximum Strategic Impact"
· Tom Gutshall, Chairman & Co-Founder of Cepheid, “Cepheid: How to Build Your Own Biotech Company”
· Tom M. Moran, J.D.., Patent Consultant, "What you Need to Know about Patents Working in Business Development"
· Michael G. McCully, M.S., Director, Deloitte Recap, “Biotech Business Development: Where Do We Go From Here”
Date and Time: Thursday and Friday, June 25-26, 2009, 8:30 am – 5 pm
Location: 10420 Bubb Road, Cupertino
Cost: $770
Course Description
UCSC Extension in Silicon Valley presents a two-day intensive course that brings the breadth of the Bay Area’s biobusiness development expertise to our Cupertino classroom. Whether financing start-up activities, trying to keep pace with the current burn rate, or moving a product into the marketplace, bioscience companies, both large and small, have a critical need for business development at every stage of their evolution. Learn the key roles that business development and licensing play in the commercialization of a new product and the development of a successful bioscience company. Cupertino, CA.
For more information and to register, see www.ucsc-extension.edu/biobizdev or call (800) 660-UNEX
**********************************************************************
Bay Bio Therapeutic Breakfast, Thursday Morning, June 25, 2009
Topic: “Biosimilars: Second Generation Biologics and Generics”
Speaker Panel:
· Speaker TBA, Government Affairs, Genentech
· Jim Hollingshead, Principal, Strategy & Operations, Deloitte Consulting LLP